Home › Myasthenia Gravis › California › Orange
Myasthenia Gravis clinical trials in Orange, CA
6 studies for Myasthenia Gravis are looking for participants at sites in and around Orange (within about 30 miles). Open a study to see who can join and how to contact the study team.
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
RecruitingPhase 1/2
- University of California Irvine, Orange
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
RecruitingPhase 2/3
- University of California, Irvine, Orange
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
RecruitingPhase 3
- University of California Irvine, Orange
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
RecruitingPhase 1
- University of California, Irvine, Orange
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
RecruitingObservational study
- Clinical Trial Site, Orange
Vitaccess Real MG Registry
RecruitingObservational study
- UCI Health, Orange
About Myasthenia Gravis
Myasthenia gravis (MG) is an autoimmune disease that weakens the muscles under your control. Find out about MG causes, symptoms, and treatment.
More about Myasthenia Gravis on MedlinePlus
Myasthenia Gravis trials in other cities
- Tampa, FL12 studies
- Houston, TX11 studies
- Durham, NC10 studies
- Boca Raton, FL10 studies
- Columbus, OH8 studies
- Miami, FL7 studies
- Milwaukee, WI7 studies
- St. Louis, MO7 studies
- New York City, NY7 studies
- Austin, TX6 studies
- Philadelphia, PA6 studies
- San Francisco, CA6 studies
Other studies in Orange
- Non-Small Cell Lung Cancer25 studies
- Metastatic Cancer20 studies
- Colorectal Cancer16 studies
- Ovarian Cancer16 studies
- Pancreatic Cancer15 studies
- Lung Cancer14 studies
- Cancer (all types)14 studies
- Melanoma14 studies
- Prostate Cancer14 studies
- Breast Cancer14 studies
- Liver Cancer (Hepatocellular Carcinoma)14 studies
- Stomach Cancer13 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.